Menu
Česky English
532 23 1111

Mezinárodní konference - 2006

Adam Z., Navratil M., Vorlicek J.: Histiocytosis from Langerhans cell in adults – experience of one department. Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellsschaften füf Hämatologie und Onkologie, Leipzig, Deutschland, 4.-8. November 2006, Abstract in: Onkologie, 29, 2006, Suppl. 3: 105, P520

  1. Adam Z., Navratil M., Vorlicek J.: Histiocytosis from Langerhans cell in adults – experience of one department. Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellsschaften füf Hämatologie und Onkologie, Leipzig, Deutschland, 4.-8. November 2006, Abstract in: Onkologie, 29, 2006, Suppl. 3: 105, P520
  2. Adam Z., Scudla V., Krejci M., Pour L., Bacovsky J., Schutzova M.,, Koza V., Tothova E.,Novosadova L., Kesler P., Zemanova M., Summa E., Svobodník A., Vorlicek L., Hajek R.: Maintenance therapy interferon alpha or sequential maintenance therapy interferon alpha and dexamethazone after high-dose chemotherapy and peripheral blood stem cell transplantation in newly diagnosed patients with multiple myeloma. Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellsschaften füf Hämatologie und Onkologie, Leipzig, Deutschland, 4.-8. November 2006, Abstract in: Onkologie, 29, 2006, Suppl. 3: 179, P762
  3. Adam Z.: Fluorodeoxyglucose positron emission tomography in multiple myeloma, solitary plasmocytoma and monoclonal gammapathy of unknown. 11th Congress of European Hematology Association, Amsterdam, the Netherlands, 15-18 June 2006, Abstract in: Heamatologica the heamatology journal 91, 2006, Suppl. 1: 90, 0239
  4. Behunová J, Kúseková M, Podracká L, Ferenczová J, Pisarčíková M, Kozák L, Kolejáková K, Petrovič R. Smith-Lemli-Opitz syndrom – fenotyp a genotyp pacientov z východného Slovenska. 20. pracovní dny "Dědičné metabolické poruchy", Sliač-Sielnica, 17.-19. květen 2006, Abstract in: Kniha abstraktov Dědičné metabolické poruchy 21. pracovné dni
  5. Brychtova Y., Doubek M., Muk J., Mayer J., Vorlicek J.: Allogeneic stem cell transplantations after reduced intensity conditioning regimen Fludarbin, Busulfan and ATG (Fresenius). 11th Congress of European Hematology Association, Amsterdam, the Netherlands, 15-18 June 2006, Abstract in: Heamatologica the heamatology journal 91, 2006, Suppl. 1: 302, 0821
  6. Brychtova Y., Doubek M., Muk J., Mayer J., Vorlicek J.: Allogeneic stem cell trnsplantations after reduced intensity conditioning regimen Fludarabin, Busulfan and ATG (Fresenius) 11th Congress of European Hematology Association, Amsterdam, the Netherlands, 15-18 June 2006, Abstract in: Heamatologica the heamatology journal 91, 2006, Suppl. 1: 302, 0821
  7. Buliková A.: Selhání antikoagulanční léčby. XIII. Slovensko-česká konferenci o hemostáze a trombóze s medzinárodnou účasťou. Martin 4.-6.května 2006
  8. Bystricka E., Vokurka S., Pavlicova V., Scudlova J., Zitkova M., et. al.: Czech and Slovak National EBMT Nurses Group – information, activities and proposals for an outreach programme comprising an institution of a Middle European National EBMT Nurser Group. 32st Annual Meeting of the European Group for Blood and Marrow Transplantation, Hamburg, Germany, 18-22 March 2006, Abstract in: Bone Marrow Transplantation 37, 2006, Suppl. 1: 260, N928
  9. Dmoszynska A., Fetni R., Wang Y., Belkaci M., Sirard C., Goldberg M., Mayer J., et al.: Cytogenetic correlation with efficacy on alemtuzumab (CAM) vs chlorambucil (CHLO) as front-line therapy for patients with progressive B–cell chronic lymphocytic leukemia (BCLL). 42nd Annual Meeting ASCO, Atlanta, Georgia, 2-6 June 2006, Abstract in: Journal of Clinical Oncology, 24, 2006, 18: 361, 6601
  10. Doubek M., Muzik J., Szotkowski T., Koza V., Cetkovsky P., Kozak T., Voglova J., Dusek L., Indrak K.: Are FLT3 ITD and D835 mutations sufficient indicators for allogeneic transplantation in acute myeloid leukemia? An analysis of patients from the Czech Acute Leukemia Clinical Registr (ALERT) 11th Congress of European Hematology Association, Amsterdam, the Netherlands, 15-18 June 2006, Abstract in: Heamatologica the heamatology journal 91, 2006, Suppl. 1: 235, 0638
  11. Drápalová I, Kozák L. Genotyp-phenotyp correlation of patients with Smith-Lemli-Opitz syndrome in relation to ApoE genotype. 20. pracovní dny "Dědičné metabolické poruchy", Sliač-Sielnica, 17.-19. květen 2006, Abstract in: Kniha abstraktov Dědičné metabolické poruchy 21. pracovné dni
  12. Dudova S., Kovarova L., Horak R., Horvath R., Penka M., Hajek R.: Amino acid seqences of T cell receptor reacting against multiple myeloma. 11th Congress of European Hematology Association, Amsterdam, the Netherlands, 15-18 June 2006, Abstract in: Heamatologica the heamatology journal 91, 2006, Suppl. 1: 451, 1255
  13. Faber E., Vitek A., Koza V., Mayer J., Sedlacek P., Zak P., Zapletalova J., Benesova K., Krejcova H., Steinerova K., Maresova I., Cetkovsky P.: Allogeneic stem cell transplantation in patients with chronic myeloid leukaemia in Czech Republic: results of a retrospective analysis from the Czech National Registry and Pilsen. 32st Annual Meeting of the European Group for Blood and Marrow Transplantation, Hamburg, Germany, 18-22 March 2006, Abstract in: Bone Marrow Transplantation 37, 2006, Suppl. 1: 226, P836
  14. Freiberger T, Grombiříková H, Kopálková L, Zapletalová E, Letocha O, Kozák L. Molecular genetic versus clinical diagnosis of familial hypercholesterolemia in Czech population. XIV International Symposium on Atherosclerosis, Rome, Italy June 18-22, 2006, Abstract in: Atherosclerosis, Vol 7, issue 3, June 2006, pp.132
  15. Gojová L, Kozák L. DNA microarrays – a significant advance in molecular diagnostics of inherited diseases. 20. pracovní dny "Dědičné metabolické poruchy", Sliač-Sielnica, 17.-19. květen 2006, Abstract in: Kniha abstraktov Dědičné metabolické poruchy 21. pracovné dni
  16. Hajek R., Krejci M., Pour L., Bolcak K., Stanicek J., Neubauer J., Adam Z.: Fluorodeoxyglucose positron emission tomography in multiple myeloma, solitary plasmocytoma and monoclonal gammapahty of unknown significance. Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellsschaften füf Hämatologie und Onkologie, Leipzig, Deutschland, 4.-8. November 2006, Abstract in: Onkologie, 29, 2006, Suppl. 3: 179, P761
  17. Hájek R., Pour L., Novotna H., Cermakova Z., Adam Z., Krejci M., Havlikova K.: Repid detection of response to bortezomibe-based regimen in mutliple myeloma using free light chain assays. 11th Congress of European Hematology Association, Amsterdam, the Netherlands, 15-18 June 2006, Abstract in: Heamatologica the heamatology journal 91, 2006, Suppl. 1: 283, 0770
  18. Hazdrova J, Hrabincova E, Kozak L. Novel 21-Hydroxylase Mutations in Czech Patients with Congenital Adrenal Hyperplasia. 20. pracovní dny "Dědičné metabolické poruchy", Sliač-Sielnica, 17.-19. květen 2006, Abstract in: Kniha abstraktov Dědičné metabolické poruchy 21. pracovné dni
  19. Hermanova M., Zapletalova E., Sedlackova J., Chrobakova T., Letocha O., Kroupova I., Zamecnik J., Vondracek P., Mazanec R., Marikova T., Vohanka S. and Fajkusova L.: Analysis of histopathologic and molecular pathologic findings in Czech LGMD2A patiens. Musile Nerve 33, 2006, 3: 424-432
  20. Hillmen P., Skotnicki A., Robak B., Jakcis B., Dmoszynka A., Sirard C., Mayer J.: Preliminary phase III efficacy and safety of alemtuzumab vs chlorambucil as fron-line therapy for patients with progressive B-cell chronic lymphocytic leukemia (BCLL). 42nd Annual Meeting ASCO, Atlanta, Georgia, 2-6 June 2006, Abstract in: Journal of Clinical Oncology, 24, 2006, 18: 339, 6511
  21. Hillmen P., Skotnicki A., Robak T., Jaksic B., Dmoszynska A., Sirard C., Mayer J.: Preliminary results for the phase III trial of alemtuzumab (campath) vs chlorambucil as first-line treatment for B-CELL chronic lymphocytic leukemia (B-CLL). 11th Congress of European Hematology Association, Amsterdam, the Netherlands, 15-18 June 2006, Abstract in: Heamatologica the heamatology journal 91, 2006, Suppl. 1: 381, 1036
  22. Hillmen P., Skotnicki A., Robak T., Jaksic B., Sirard C., Mayer J.: Alemtuzumab (campath, mabcampanth) has superior progression fee (PFS) vs chlorambucil as front-line therapy for patients with progressive B-Cell chronic lymphocytic leukemia (BCLL). 48th Annual Meeting of the American Society of Hematology, Orlando, Florida, 9-12 December 2006, Abstract in: Blood 108, 2006, 11: 93b, 301
  23. Horky O., Mayer J., Borsky M., Pospisilova J., Krejci M., Dvorakova D.: Dynamics of lineage-specific chimerism in patients after non-myeloablative hematopoietic stem cell transplantation. 11th Congress of European Hematology Association, Amsterdam, the Netherlands, 15-18 June 2006, Abstract in: Heamatologica the heamatology journal 91, 2006, Suppl. 1: 304, 0827
  24. Hrabincova E, Kintr J, Horky O, Zapletalova P, Drapalova I, Prochazkova D, Kozak L. Identification and characterization of large deletions in the phenylalanine hydroxylase (PAH) gene by MLPA and Long-range PCR. 20. pracovní dny "Dědičné metabolické poruchy", Sliač-Sielnica, 17.-19. květen 2006, Abstract in: Kniha abstraktov Dědičné metabolické poruchy 21. pracovné dni
  25. Huser M., Crha I., Hudecek R., Ventruba P., Zakova J., Smardova L., Kral Z.: Gonadal protection with GnRH analogues during chemotherapy – cytotoxic dose derived cohort study (OVARONKO). 12th World Congress of Gynecological Endocrinology, Florence, 2.-5. March 2006, Abstract in: Gynecological endocrinology, 22, 2006, Suppl. 1: 152, OP87
  26. Chumchalova J., Trbusek M., Bukovska S., Klabusay M., Pospíšil Z., Vasova I., Oborilova A., Dvorakova D., Mayer J.: Enexpected antagonictic effect of rituximab with procarbazine dislosed during an in vitro testing of rituximab-mediated sensitizacion of B-CELL. 11th Congress of European Hematology Association, Amsterdam, the Netherlands, 15-18 June 2006, Abstract in: Heamatologica the heamatology journal 91, 2006, Suppl. 1: 409, 1119
  27. Chumchalová, J., Klimešová, D., Kuhrová, V., Francová, H., Brychtová, Y., Doubek, M., Dvořáková, D., Mayer, J.: Constitutive activation of STAT1 and STAT3 proteins on serine and tyrosine residues were found in majority of CLL patients. 48th Annual Meeting of the American Society of Hematology, Orlando, Florida, 9-12 December 2006, Abstract in: Blood 108, 2006, 11: 319b, 4931
  28. Indrak K., Doubek M., Voglova J., Koza V., Kozák T., Szotkowski T., Mayer J., et al.: Analysis of 1458 acute myeloid leukemia from the ALERT project (acute leukemia clinical register) in the Czech Republic in 1996-2006. 11th Congress of European Hematology Association, Amsterdam, the Netherlands, 15-18 June 2006, Abstract in: Heamatologica the heamatology journal 91, 2006, Suppl. 1: 43, 0115
  29. Jerabkova B., Fajkusova L., Kozak L., Buckova H.: Experience with mutation analysis of epidermolysis bullosa in Czech Republic. 2nd Eastern European Conference on Rare Diseases and Orphan Drugs. 8.9. – 9.9. 2006, Plovdiv, Bulgaria. Abstrack in: Abstract book, p.52
  30. Jerabkova B., Stehlíková K., Hermanova M., Fajkusova L.: Analysis of molecular pathologic findings in Czech LGMD2A patients. 2nd Eastern European Conference on Rare Diseases and Orphan Drugs. 8.9. – 9.9. 2006, Plovdiv, Bulgaria. Abstrack in: Abstract book, p.124
  31. Kajaba V., Labudikova M., Novak L., Bystricka E., Zitkova M., Moravcova K., Pavlicova V., Vitkova J., Rehorova I., Finova L., et. al.: How patients evaluace health related quality of life after aulogous stem cells transplantation in the Czech Republic - QOL-A.2004, a mulicentre prospective study. 32st Annual Meeting of the European Group for Blood and Marrow Transplantation, Hamburg, Germany, 18-22 March 2006, Abstract in: Bone Marrow Transplantation 37, 2006, Suppl. 1: 296, P1045
  32. Klabusay M., Koristek Z., Vinklarkova J., Mayer J.: Shortening of neutropenia in lymphoma patients after transplantation of lin enriched cells expanded ex vivo. 11th Congress of European Hematology Association, Amsterdam, the Netherlands, 15-18 June 2006, Abstract in: Heamatologica the heamatology journal 91, 2006, Suppl. 1: 134, 0362
  33. Kolegarová O., Zítková M.: Communication of nurses with dying patients and thein significant ones. EONS Spring Convention, Insbruck, Austria, 20-22 April 2006, Abstract in: European Journal of Oncology Nursing 10, 2006, 3: Poster 7
  34. Koristek Z., Navratil M., Mayer J., Doubek M.: Is leukapherisis able to improve survival in hyperleukocytic aml if used as the early cytoreduction treatment? 11th Congress of European Hematology Association, Amsterdam, the Netherlands, 15-18 June 2006, Abstract in: Heamatologica the heamatology journal 91, 2006, Suppl. 1: 486, 1365
  35. Kotašková J., Tichý B., Malčíková J., Trbušek M., Brychtová Y., Doubek M., Mayer J. and Pospíšilová Š. Expression analysis of chronic lymphocytic leukemia B-cells with different IgVH mutational status. Genomics and Cancer 2006, Heidelberg, Německo, 13-16.9.2006, Abstrakt book p.115. Poster.
  36. Kovářová L., Michálek J., Penka M., Hájek R.: CD40 ligand and calcium ionophore treatment of dendritic cells from healthy donors and patients with monoclonal gammopathy of unknown significance and Multiple myeloma. 11th Congress of the European Hematology Association, the Netherlands, Amsterdam, 15 – 18 . 6 .2006, Abstrakt in.: Book haematologica/the hematology journal,2006: 91(s1), pp451
  37. Kozák L, Hrabincová E, Kintr J, Horký O, Zapletalová P, Drápalová I, Procházková D. Identification and characterization of large deletions in the phenylalanine hydroxylase (PAH) gene. 10th International Congress of Inborn Errors of Metabolism (ICIEM), Chiba, Japan, 12-16 September 2006, Abstract in.: Journal of Inherited Metabolic Disease, 2006, Vol 29, Suppl. 1, pp. 97
  38. Kozak L, Vrabelova S, Letocha O, Borsky M. Mutation analysis of the ATP7B gene and genotype/phenotype correlation in patients with Wilson disease from Czech Republic. International Workshop on Wilson Disease and Other Disorders of Copper Metabolism, Bethesda, USA, November 2-3, 2006, Abstract in NINDS International Workshop on Wilson’s Disease and Other Disorders of Copper Metabolism
  39. Kozák L. Molecular genetic diagnosis in metabolic disorders.20. pracovní dny "Dědičné metabolické poruchy", Sliač-Sielnica, 17.-19. květen 2006, Abstract in: Kniha abstraktov Dědičné metabolické poruchy 21. pracovné dni
  40. Kozák L., Hrabincová E., Kintr J., Horký O., Zapletalová P., Blaháková I., Mejstřík P., Procházková D.: Identification and characterization of large deletions in the phenylalanine hydroxylase (PAH) gene by MLPA: Evidence for both homologous and non-homologous mechanisms of rearrangement. Molecular Genetics and Metabolism 89, 2006, 300-309
  41. Krejci M., Hajek R., Svobodnik A., Krivanova A., Adam Z., Pour L., Vorlicek J.: Simple, but significant factors for survival after autologous transplantation in 181 multiple myeloma patients: a single centre experience. 11th Congress of European Hematology Association, Amsterdam, the Netherlands, 15-18 June 2006, Abstract in: Heamatologica the heamatology journal 91, 2006, Suppl. 1: 85, 0225
  42. Krejci M., Mayer J., Doubek M., Brychtova Y., Kamelander J., Vorlicek J.: High efficacy of pulse cyclophosphamide in corticosteroid-refractory liver graft-versus-host disease. 11th Congress of European Hematology Association, Amsterdam, the Netherlands, 15-18 June 2006, Abstract in: Heamatologica the heamatology journal 91, 2006, Suppl. 1: 118, 0317
  43. Lauschová I., Horký D., Klabusay M., Palša S., Sheer P.: Distribution of bone marrow mononuclear cells in experimental myocardial infarction. 43rd International Congress on Anatomy, Prague, 2006, lecture. Bez abstract
  44. Lochmanova J., Racil Z., Lengerova M., Minarikova D., Dvorakova D., Mayer J.: Advances in PCR detection of Pneumocystis jiroveci in immunocompromised patients: count seems to be important. 16th European Congress of Clinical Microbiology and Infectious Diseases. Nice, France, 1-4 April 2006, Abstract in: Clinical Microbiology and Infection 12, 2006, 3: p964
  45. Malcikova J., Damborsky J., Tichy B., Kotaskova J., Trbusek M., Mayer J., Pospisilova S.: Application of functional protein microarrays for detection of p53 mutant aktivity. Advances in Microarray technology. Amsterdam, Holandsko 31.10.-2.11.2006. Abstrakt CD
  46. Malčíková J., Trbušek M., Šmardová J., Bukovská S., Kuglík P., Brychtová Y., Doubek M., Mayer J. and Pospíšilová Š. Importance of p53 status detection in patients with B-cell chronic lymphocytic leukemia – relevance to prognosis and treatment. Genomics and Cancer 2006, Heidelberg, Německo, 13-16.9.2006, Abstrakt book p.118. Poster.
  47. Mayer J., Klabusay M., Koristek Z., Doubek M., Navratil M., Kren L., Palsa S., Pospisilova S., Tichy B., Kohoutova V., Vorlicek J., Groch L., Meluzin J., Rauser P., Vlasin M.: Continuous ifusion instead of repeated boluses of bone marrow-derived mononuclear cells into the coronary. 32st Annual Meeting of the European Group for Blood and Marrow Transplantation, Hamburg, Germany, 18-22 March 2006, Abstract in: Bone Marrow Transplantation 37, 2006, Suppl. 1: 225, P833
  48. Mayer J., Krejci M., Doubek M., Brychtova Y., Dvorakova D., Legnerova M., Horky O.: Non-myeloablative allogeneic haematopoetic stem cell transplantation for CML in 1st chronic phase: curative potential and cost comparison with hypothetical imantinib treatment. 32st Annual Meeting of the European Group for Blood and Marrow Transplantation, Hamburg, Germany, 18-22 March 2006, Abstract in: Bone Marrow Transplantation 37, 2006, Suppl. 1: 43, O331
  49. Mayer, J., Palásek, I., Pospíšil, Z., Štruncová, S., Dvořáková, D., Borský, M., Klabusay, M., Doubek, M., Brychtová, Y., Ráčil, Z: Detection of molecular relapse of AML by very frequent quantitative monitoring of different molecular markers (fusion transcripts and WT1) in different compartments (peripheral blood-PB, bone marrow-BM, and selected CD34+ bone marrow cells) and its treatment with chemotherapy or gentuzumab ozogamicin. 48th Annual Meeting of the American Society of Hematology, Orlando, Florida, 9-12 December 2006, Abstract in: Blood 108, 2006, 11: 199b, 4481
  50. Michalek J., Dudova S., Lotarova L., Penka M., Hajek R.: Identification of individual autologous T-cell clones reactive againts multiple myeloma. 32st Annual Meeting of the European Group for Blood and Marrow Transplantation, Hamburg, Germany, 18-22 March 2006, Abstract in: Bone Marrow Transplantation 37, 2006, Suppl. 1: 140, P601
  51. Navratil M., Koristek Z., Tomiska M., Doubek M., Krejci M., Brychtova Y., Mayer J.: Haemolysis as complication of conditioning regimens containing ATG (Fresenius) 32st Annual Meeting of the European Group for Blood and Marrow Transplantation, Hamburg, Germany, 18-22 March 2006, Abstract in: Bone Marrow Transplantation 37, 2006, Suppl. 1: 254, P911
  52. Ocadlikova D., Zahradova L., Kovarova L., Penka M., Hajek R., Michalek J.: The preparation of myeloma-specific cytotoxic T cells based on interferon γ production. 11th Congress of European Hematology Association, Amsterdam, the Netherlands, 15-18 June 2006, Abstract in: Heamatologica the heamatology journal 91, 2006, Suppl. 1: 451, 1254
  53. Petrášek, Trunečka, Jirsa, Šperl, Drastich, Kozák L a Špičák. Diagnostic and predictive indexes in patients with fulminant and chronic decompensated Wilson´s disease. 41st Annual Meeting of the European Association for the Study Of The Liver, Vienna, Austria, April 26 -30, 2006, Bez abstract
  54. Pospíšilová Š., Kusenda B., Kozubíková K., Kaplanová A., Tichý B., Mayer J. Specific Silencing of Mutant Antioncogene p53 by RNA Interference. RNAi Europe, Praha, 28-29.9.2006. Abstract on CD, přednáška
  55. Pospíšilová Š., Malčíková J., Damborský J., Šmardová J., Trbušek M., Tichý B., Brychtová Y., Doubek M., Vorlíček J., Mayer J. Role of p53 Mutation Type in B-CLL Prognosis. 48th Annual Meeting of the American Society of Hematology, Orlando, Florida, 9-12 December 2006, Abstract in: Blood 108, 2006, 11: 159b-160b, 4324
  56. Pospíšilová Š., Tichý B., Malčíková J., Kotašková J., Kusenda B., Juračková L., Trbušek M., Mayer J.: Genomic and proteomic approaches to the analysis of  p53 activity in tumor cells. XX. Biochemický zjazd. Piešťany. Slovensko 12.-16.10.2006 Abstrakt book p.60
  57. Pour L., Hajek R., Adam Z., Krejci M., Krivanova A., Zahradova L., Buchler T., Vorlicek J.: Exanthema and herpes zoster infection during Velcade use incidence, treatment and profylaxis. 11th Congress of European Hematology Association, Amsterdam, the Netherlands, 15-18 June 2006, Abstract in: Heamatologica the heamatology journal 91, 2006, Suppl. 1: 443, 1227
  58. Pour L., Smolej L., Hájek R., Maisnar V., Adam Z., Krejčí M., Penka M.: Hodnocení angiogenetického profilu ve dřeni a periferní krvi u pacientů s mnohočetným myelomem. II.Bratislavské hematologické a transfuziologické dni s mezinárodnou účastku, Bratislava, 26.-27.10.2006, Abstrakt in: Interná medicína,2006: 6(S2), pp42S, P 14
  59. Procházková D, Konečná P, Kozák L, Hrabincová E, Severová J, Vinohradská H, Ventruba P, Hrstková H. PKU in adulthood - maternal PKU. 20. pracovní dny "Dědičné metabolické poruchy", Sliač-Sielnica, 17.-19. květen 2006, Abstract in: Kniha abstraktov Dědičné metabolické poruchy 21. pracovné dni
  60. Procházková D, Konečná P, Kozák L, Hrabincová E, Severová J, Vinohradská H, Ventruba P, Hrstková H. Maternal PKU in the Moravian region (Czech Republic).10th International Congress of Inborn Errors of Metabolism (ICIEM), Chiba, Japan, 12-16 September 2006, Bez abstrack
  61. Racil Z., Kocmanova I., Kubicova E., Lochmanova J., Sevcikova A., Mayer J.: Variation of galactomannan level during 24-hour period in heamatooncological patients with/withou invasise aspergillosis. 16th European Congress of Clinical Microbiology and Infectious Diseases. Nice, France, 1-4 April 2006, Abstract in: Clinical Microbiology and Infection 12, 2006, 3: p729
  62. Racil Z., Malaskova L., Wagnerova B., Kocmanova I., Doubek M., Mayer J.: Usefulness of the voriconazole plasma levels monitoring in hematooncological pts treated by oral form the voriconazole. 11th Congress of the European Hematology Association, Amsterdam, Netherlands, 15-18 June 2006. Abstract in: Heamatologica 91, 2006, Suppl. 1: 511, 1443
  63. Robak T., Dmoszynska A., Fetni R., Wang Y., Belkatz M., Sirard C., Goldberg M., Skotnicki A., Mayer J., Hillmen P.: Incidence of genomic aberrations and associated efficacy from a Phase III study comparing alemtuzumab vs chlorambucil as first line therapy for B-Cell Chronic Lymphocytic Leukemia (BCLL). 48th Annual Meeting of the American Society of Hematology, Orlando, Florida, 9-12 December 2006, Abstract in: Blood 108, 2006, 11: 593a, 2092
  64. Sedláčkova J., Fajkusova L., Lukáš Z.: Molecular genetic diagnostics of myotonic dystrophy and facioscapulohumeral muscular dystrophy in Czech patiens. 11th International Congress of the WMS, 4.10.-7.10.2006, Bruges, Belgium. Abstract in: Neuromuscular Disorders, 2006, 16: 672
  65. Smejkalova J., Kugllik P., Filkova H., Oltova A., Adam Z., Pour L., Krejci M., Penka M., Hajek R.: Correlation between the cytogenetic findings and the prognostic factors in the group of patients from the CMG 2002 clinical study.11th Congress of European Hematology Association, Amsterdam, the Netherlands, 15-18 June 2006, Abstract in: Heamatologica the heamatology journal 91, 2006, Suppl. 1: 275, 0747
  66. Smolej L., Andrys C., Belada D., Pour L., Zak P., Krejsek J., Novosad J.,  Hrudkova M., Siroky O., Voglova J., Maly J.: Plasma soluble endoglin (sCD105)  concentrations in patients with lymphoid malignancies - a pilot study. 46th Annual Scientific Meeting, 3-5 April 2006, Edinburgh, Abstract in: Br J Haem  2006;133 (Suppl.1):104 (abstract 269) IF=4,080
  67. Stehlíková K., Zapletalova E., Sedláčkova J., Hermanová M., Vondráček P., Marikova T., Mazanec R., Zamecnik J., Vohanka S., Fajkus J., and Fajkusova L.: Quantitative analysis of CAPN3 transcripts in LGMD2A patients: Involvement of nonsense-mediated mRNA decay. Bez abstract
  68. Trbušek, M., Čejková, S., Chumchalová, J., Pospíšil, Z., Šmardová, J., Kuglík, P., Doubek, M., Brychtová, Y., Pospíšilová, Š, Mayer, J.: Rituximab senzitizes B-CLL cells with inactivated p53 to fludarabine. American society of Hematology, 48th Annual Meeting of the American Society of Hematology, Orlando, Florida, 9-12 December 2006, Abstract in: Blood 108, 2006, 11: 331b, 4973
  69. Trneny M., Belada D., Vasova I., Pytlik R., Kozak T., Sykorova., Kubackova K., Pirnos J., Bolmska I., Hamouzkova M.: Rituximab significanly improves the outcome of young poorrisk patients with diffuse large B-cell lymphoma on behalf Czech Lymphoma Study Group. 11th Congress of European Hematology Association, Amsterdam, the Netherlands, 15-18 June 2006, Abstract in: Heamatologica the heamatology journal 91, 2006, Suppl. 1: 261, 0707
  70. Trunečka, Petrášek, Jirsa, Šperl, Drastich, Kozák L a Špičák: Validation of diagnostic and predictive indexes in patients with fulminant and chronic decompensated Wilson´s disease. Digestive Disease Week 2006, Los Angeles, USA, May 20-25, 2006, Bez abstract
  71. Valkova V., Vitek A., Faber E., Mayer J., Zak P., Benesova K., Trneny M.: Allogenic stem cell trnsplantation for NHL: Data from National Czech registry. 48th Annual Meeting of the American Society of Hematology, Orlando, Florida, 9-12 December 2006, Abstract in: Blood 108, 2006, 11: 159b-160b, 5375
  72. Vasickova P., Lukesova M., Horky O., Pavlu H., Kuklova J., Urbankova V., Navratilova M., Machackova E., Foretova L.: BCRA1 intragenic rearrangements in patients wiht hereditary breast and ovarian cancer syndrome in the Czech Republic. European Human Genetics Conference, Amsterdam, 6-9 May 2006, Abstract in: European Journal of Human Genetics, 14, 2006, suppl. 1: 208, P0506
  73. Vasova I., Elbl L., Navratil M., Tomaskova I., Kral Z., Salek Z., Jedlicka F., Smardova L., Mayer J.: The late cardiotoxicity of doxorubicin containing regimens in the treatment of malignant lymphomas. 11th Congress of European Hematology Association, Amsterdam, the Netherlands, 15-18 June 2006, Abstract in: Heamatologica the heamatology journal 91, 2006, Suppl. 1: 264, 0717
  74. Vasova I., Pytlik R., Belada D., Jankovska M., Kubackova K., Pironos J., Matuska M., Bolomska I., Trneny M., Hamouzova M.: The occurrence of CNS relapses in high-risk aggressive lymphoma patients treated with intensified induction and high-dose consolidation protocols of teh Czech Lymphoma Study Group. 11th Congress of European Hematology Association, Amsterdam, the Netherlands, 15-18 June 2006, Abstract in: Heamatologica the heamatology journal 91, 2006, Suppl. 1: 258, 0700
  75. Vidláková P., Smejkalová J., Očadlíková D., Pour L., Kovářová L., Hanák L., Hájek R., Penka M., Oltová A., Kocák I., Fait V., Žaloudík J., Michálek J.: Využití in vitro expandovaných tumor infiltrujících lymfocytů u pacientů s metastazujícím melanomem. II.Bratislavské hematologické a transfuziologické dni s mezinárodnou účastku,Bratislava,26.-27.10.2006 Abstrakt in: Interná medicína,2006: 6(S2), pp44S, P21
  76. Vigasova V., Kadlecova J., Spesna R., Gaiyllova R., Penka M., Michalka J., Hajek R.: Relative Quantification of tumor associated antigens MAGE-A1 and MAGE-A3 in multiple myeloma. 11th Congress of European Hematology Association, Amsterdam, the Netherlands, 15-18 June 2006, Abstract in: Heamatologica the heamatology journal 91, 2006, Suppl. 1: 95, 0252
  77. Vrábelová S, Francová H, Kozák L. Mutation analysis of the GALT gene in the patients with galactosemia. 20. pracovní dny "Dědičné metabolické poruchy", Sliač-Sielnica, 17.-19. květen 2006 Abstract in: Kniha abstraktov Dědičné metabolické poruchy 21. pracovné dni
  78. Zapletalova E., Vondráček P., Jeřábkova B., Gaillyova R., Fajkusova.: Correlation between SMN2 copy numer variations in expression of SMN2 mRNA and clinical outcome in SMA patiens treated with phenylbutyrate and valproic acid. 11th International Congress of the WMS, 4.10.-7.10.2006, Bruges, Belgium. Abstract in: Neuromuscular Disorders 16, 2006, 644-726: N.P.2 03
  79. Zapletalová P, Kintr J, Letocha O, Mejstřík P, Goldmann R, Kozák L. Improvement of DNA analysis in LDL receptor gene using multiplex ligation-dependent probe amplification (MLPA) technique. 20. pracovní dny "Dědičné metabolické poruchy", Sliač-Sielnica, 17.-19. květen 2006 Abstract in: Kniha abstraktov Dědičné metabolické poruchy 21. pracovné dni
  80. Zitkova M., Danisova Z., Finova L., Racil Z., Kocmanova I.: Influence of preventive measures to prevent the spread of vancomycin-resistant enterococci in haemato-onkological patients. 32st Annual Meeting of the European Group for Blood and Marrow Transplantation, Hamburg, Germany, 18-22 March 2006, Abstract in: Bone Marrow Transplantation 37, 2006, Suppl. 1: 292, P1034
Informace o pohotovosti v Brně a Jihomoravském kraji